Recent Articles By The Author
It is good to be sitting in for Doug Kass here on The Daily Diary as we open trading in the second half of 2019. June ended on an up note as all the major indices drifted up last week to close out the month and quarter. The market did an admirable j...
The drop in AbbVie's stock price following revelation of its plans to buy Allergan provides a way to hit a solid investment single using a buy-write options strategy.
The names include a veterinary drug concern plus companies with successful drugs on the market.
These two firms have successful drugs and could make nice additions for larger companies.
Mortgage rates have been declining of late, which should help produce a better story for the housing market in the second part of 2019.
Recent insider buys in Occidental Petroleum and Flotek Industries during the energy dip may be sign of potential investment opportunities.